DESOGESTREL Drug Patent Profile

When do Desogestrel patents expire, and when can generic versions of Desogestrel launch?

Desogestrel is a drug marketed by Duramed Pharms Barr, Annora Pharma, Dr Reddys Labs Sa, Naari Pte, Novast Labs, Watson Labs, and Xiromed. and is included in ten NDAs.

The generic ingredient in DESOGESTREL is desogestrel; ethinyl estradiol. There are eight drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the desogestrel; ethinyl estradiol profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Desogestrel

A generic version of DESOGESTREL was approved as desogestrel; ethinyl estradiol by DURAMED PHARMS BARR on August 12^th, 1999.

Summary for DESOGESTREL

US Patents:	0
Applicants:	7
NDAs:	10
Drug Prices:	Drug price information for DESOGESTREL
DailyMed Link:	DESOGESTREL at DailyMed

See drug prices for DESOGESTREL

US Patents and Regulatory Information for DESOGESTREL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Duramed Pharms Barr	DESOGESTREL AND ETHINYL ESTRADIOL	desogestrel; ethinyl estradiol	TABLET;ORAL-21	075256-001	Aug 12, 1999		DISCN	No	No
Naari Pte	DESOGESTREL AND ETHINYL ESTRADIOL	desogestrel; ethinyl estradiol	TABLET;ORAL-28	207067-001	Sep 13, 2018	AB	RX	No	No
Dr Reddys Labs Sa	DESOGESTREL AND ETHINYL ESTRADIOL	desogestrel; ethinyl estradiol	TABLET;ORAL-28	077182-001	Jan 24, 2006		DISCN	No	No
Novast Labs	DESOGESTREL AND ETHINYL ESTRADIOL	desogestrel; ethinyl estradiol	TABLET;ORAL-28	091234-001	Jul 12, 2013	AB	RX	No	No
Annora Pharma	DESOGESTREL AND ETHINYL ESTRADIOL	desogestrel; ethinyl estradiol	TABLET;ORAL-28	219761-001	Mar 18, 2026	AB	RX	No	No

DrugChatter Q&A for DESOGESTREL

Tab desogestrel and ethinyl estradiol?